Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Other Liabilities
|
Adaptive Biotechnologies Corp
Other Liabilities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Other Liabilities
$262.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Liabilities
$4.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Liabilities
$5.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Liabilities
$306.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Liabilities
$588m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Liabilities
$921m
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
18%
|
See Also
What is Adaptive Biotechnologies Corp's Other Liabilities?
Other Liabilities
262.6m
USD
262.6m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Other Liabilities amounts to 262.6m USD.
What is Adaptive Biotechnologies Corp's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
0%
0%
Over the last year, the Other Liabilities growth was -5%. The average annual Other Liabilities growth rates for Adaptive Biotechnologies Corp have been 3% over the past three years .
You don't have any saved screeners yet
